Skip Nav Destination
Abstract P4-22-08: A single-arm phase 2 study to assess clinical activity, efficacy and safety of enzalutamide with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer
Cancer Res (2017) 77 (4_Supplement): P4-22-08.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Nusrat Jahan
- Catherine Jones
- Rakhshanda Layeequr Rahman
Molecular and Cellular Endocrinology (2021) 531: 111324.
- Hervé Bonnefoi
- Gaetan MacGrogan
- Coralie Poncet
- Richard Iggo
- Fanny Pommeret
- Thomas Grellety
- Denis Larsimont
- Véronique Bécette
- Olivier Kerdraon
- Frédéric Bibeau
- Jean-Pierre Ghnassia
- Jean-Michel Picquenot
- Jeremy Thomas
- Jean-Christophe Tille
- Leen Slaets
- Alexandre Bodmer
- Jonas Bergh
- David Cameron
British Journal of Cancer (2019) 120 (9): 913.
- Elisabetta Pietri
- Ilaria Massa
- Sara Bravaccini
- Sara Ravaioli
- Maria Maddalena Tumedei
- Elisabetta Petracci
- Caterina Donati
- Alessio Schirone
- Federico Piacentini
- Lorenzo Gianni
- Mario Nicolini
- Enrico Campadelli
- Alessandra Gennari
- Alessandro Saba
- Beatrice Campi
- Linda Valmorri
- Daniele Andreis
- Francesco Fabbri
- Dino Amadori
- Andrea Rocca
The Oncologist (2019) 24 (6): 743.
- C. Schem
- N. Maass
- M. Elessawy
- M. van Mackelenbergh
- T. Heilmann
Der Gynäkologe (2017) 50 (7): 516.